These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24669377)

  • 1. Preface.Pathogenesis of Mycobacterium tuberculosis and its interaction with the host organism.
    Pieters J; McKinney J
    Curr Top Microbiol Immunol; 2013; 374():v-vi. PubMed ID: 24669377
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved understanding of pathogenesis from protein interactions in Mycobacterium tuberculosis.
    Cui T; He ZG
    Expert Rev Proteomics; 2014 Dec; 11(6):745-55. PubMed ID: 25327725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-pathogen interactions during Mycobacterium tuberculosis infections.
    Stanley SA; Cox JS
    Curr Top Microbiol Immunol; 2013; 374():211-41. PubMed ID: 23881288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis.
    David S; Mateus AR; Duarte EL; Albuquerque J; Portugal C; Sancho L; Lavinha J; Gonçalves G
    PLoS One; 2015; 10(11):e0140625. PubMed ID: 26529092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic study of Mycobacterium tuberculosis and its clinical applications.
    Tyagi JS; Sharma D
    Indian J Pediatr; 2002 Nov; 69 Suppl 1():S29-38. PubMed ID: 12501923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of drug resistance in Mycobacterium tuberculosis.
    Smith T; Wolff KA; Nguyen L
    Curr Top Microbiol Immunol; 2013; 374():53-80. PubMed ID: 23179675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-resistant tuberculosis among previously treated patients in Yangon, Myanmar.
    Tun T; Nyunt WW; Latt KZ; Samaranayaka A; Crump JA; Thinn KK; Cook GM; Aung HL
    Int J Mycobacteriol; 2016 Sep; 5(3):366-367. PubMed ID: 27847028
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluorescent Mycobacterium tuberculosis reporters: illuminating host-pathogen interactions.
    MacGilvary NJ; Tan S
    Pathog Dis; 2018 Apr; 76(3):. PubMed ID: 29718182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis strain 18b, a useful non-virulent streptomycin dependent mutant to study latent tuberculosis as well as for in vivo and in vitro testing of anti-tuberculosis drugs.
    Campos-Neto A
    Tuberculosis (Edinb); 2016 Jul; 99():54-55. PubMed ID: 27450005
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycobacterium tuberculosis and the macrophage: maintaining a balance.
    Pieters J
    Cell Host Microbe; 2008 Jun; 3(6):399-407. PubMed ID: 18541216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tuberculosis X factor.
    Lancet Infect Dis; 2006 Nov; 6(11):679. PubMed ID: 17067912
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.
    Mnyambwa NP; Kim DJ; Ngadaya ES; Kazwala R; Petrucka P; Mfinanga SG
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2021-2028. PubMed ID: 28593375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The surprising diversity of Mycobacterium tuberculosis: change you can believe in.
    Fortune SM
    J Infect Dis; 2012 Dec; 206(11):1642-4. PubMed ID: 22984117
    [No Abstract]   [Full Text] [Related]  

  • 15. PUPylation provides the punch as Mycobacterium tuberculosis battles the host macrophage.
    Salgame P
    Cell Host Microbe; 2008 Nov; 4(5):415-6. PubMed ID: 18996341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis: Smart manipulation of a lethal host.
    Chaurasiya SK
    Microbiol Immunol; 2018 Jun; 62(6):361-379. PubMed ID: 29687912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance to Mycobacterium tuberculosis: from the traditional Chinese view to modern systems biology.
    Xu Y; Zhang Z; Sun Z
    Crit Rev Microbiol; 2015; 41(3):399-410. PubMed ID: 24433008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis metabolism and host interaction: mysteries and paradoxes.
    Ehrt S; Rhee K
    Curr Top Microbiol Immunol; 2013; 374():163-88. PubMed ID: 23242856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives.
    Gygli SM; Borrell S; Trauner A; Gagneux S
    FEMS Microbiol Rev; 2017 May; 41(3):354-373. PubMed ID: 28369307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.
    Szumowski JD; Adams KN; Edelstein PH; Ramakrishnan L
    Curr Top Microbiol Immunol; 2013; 374():81-108. PubMed ID: 23242857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.